Examining the Role of a Functional Deficiency of Iron in Lysosomal Storage Disorders with Translational Relevance to Alzheimer's Disease. [PDF]
LeVine SM.
europepmc +3 more sources
Genetic Insights and Diagnostic Challenges in Highly Attenuated Lysosomal Storage Disorders [PDF]
Urizar E +17 more
europepmc +3 more sources
Prevalence of lysosomal storage disorders in Australia from 2009 to 2020. [PDF]
Chin SJ, Fuller M.
europepmc +2 more sources
Unsheathing new insights into lysosomal storage disorders
Kirsty M. Hooper
doaj +2 more sources
The pathogenesis of lysosomal storage disorders: beyond the engorgement of lysosomes to abnormal development and neuroinflammation. [PDF]
M. Fiorenza, E. Moro, R. Erickson
semanticscholar +2 more sources
Defects in the medial entorhinal cortex and dentate gyrus in the mouse model of Sanfilippo syndrome type B. [PDF]
Sanfilippo syndrome type B (MPS IIIB) is characterized by profound mental retardation in childhood, dementia and death in late adolescence; it is caused by deficiency of α-N-acetylglucosaminidase and resulting lysosomal storage of heparan sulfate.
Neufeld, Elizabeth F +2 more
core +15 more sources
Lysosomal storage diseases [PDF]
Lysosomes play a pivotal role in cellular processes through an active interplay of enzymes, lysosomal membrane proteins, and cytosolic proteins. Lysosomal storage diseases are a group of inherited and acquired disorders.
Smitha Rose Georgy
doaj +1 more source
Advances in therapies for neurological lysosomal storage disorders
Lysosomal Storage Disorders (LSDs) are a diverse group of inherited, monogenic diseases caused by functional defects in specific lysosomal proteins.
S. Ellison, H. Parker, B. Bigger
semanticscholar +1 more source
mTORC1 hyperactivation arrests bone growth in lysosomal storage disorders by suppressing autophagy. [PDF]
Rosa Bartolomeo +13 more
semanticscholar +2 more sources
Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development
Rare monogenic disorders such as lysosomal diseases have been at the forefront in the development of novel treatments where therapeutic options are either limited or unavailable.
G. Massaro +7 more
semanticscholar +1 more source

